More than 250 high-level education policymakers, industry leaders, technology experts, and gamers gathered at The Gallup Building in Washington, D.C. for The Atlantic’s second annual Technologies in Education Forum on Tuesday, May 22, 2012. The full-day program featured six sessions focusing on emerging policies and cutting-edge technologies available to educators, particularly those teaching science and math.
Please select a player below to view the video from our Forum.
HEADLINE REMARKS – Paula Kerger, President and Chief Executive Officer, PBS:
PANEL DISCUSSION – Education and Engagement: Framing the Role Games Will Play in Future Learning:
PANEL DISCUSSION – Stand and Deliver: The Role Teachers Will Play in Game-Based Learning:
PANEL DISCUSSION – How Educational Technology Will Train Future Workers for Next Wave Jobs:
KEYNOTE SPEECH – Tom Kalil, Deputy Director, White House Office of Science and Technology Policy and HEADLINE INTERVIEW – Joel Klein, Executive Vice President, News Corporation; Former Chancellor, New York City Department of Education:
Also in This Series
Technologies in Education 2014
For the fourth year in a row, The Atlantic examined the new policies and tools that are revolutionizing the way our students learn and our teachers teach, from educational video gaming to online learning.
Technologies in Education Forum 2013
For the third year in a row, The Atlantic examined the new policies and tools available to those working on the front lines to bolster American student learning and achievement.
Featuring Graham Allison
and Jeffrey Goldberg
Graham Allison, Director of Harvard University's Belfer Center for Science and International Affairs, and author of Destined for War: Can America and China Escape Thucydides’s Trap?, will join The Atlantic’s Editor in Chief Jeffrey Goldberg to explore the US-China relationship and see how war in East Asia can be avoided.
The Next Drugs:
An Atlantic Policy Update on Biosimilars
The Atlantic will convene key stakeholders to discuss the state of and future for biosimilars.